SOX17 and uterine corpus endometrial carcinoma: A similar behavior was observed for SOX17, which was predicted as an oncogene in uterine corpus endometrial carcinoma associated with promoter peaks and as a tumor suppressor associated with hypermethylation in lung squamous cell carcinoma (Supplementary Data 7,, 8; Methods) These findings were confirmed by ChipSeq of SOX17 in endometrial cancer39, while SOX17 suppressed cell proliferation and promoter hypermethylation has been shown in lung cancer40.